---
edited: 2024-03-02
tags:
---

| Aspect                         | Details                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| ------------------------------ | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| **Definition**                 | Malformed tricuspid valve leaflets displaced into the right ventricle, leading to tricuspid valve regurgitation and right heart enlargement (RV "atrialization")                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| **Associated Cardiac Defects** | - Interatrial communication (e.g., PFO, ASD) in ∼ 90% of patients<br>- Conduction disorders (e.g., Wolff-Parkinson-White syndrome, supraventricular tachycardia)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| **Epidemiology**               | - Prevalence: 0.5–1/10,000 live births in the US<br>- Accounts for < 1% of all CHD cases                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| **Etiology**                   | - Multifactorial (most cases sporadic)<br>- Associated with prenatal [[lithium]] exposure<br>- Isolated genetic defects (e.g., MYH7 gene)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| **Pathophysiology**            | Incomplete delamination (i.e., separation of valve tissue from the myocardium) during valve development can lead to one or more of the following: <br>- Incomplete closure of the right atrioventricular valve and reduction in RV volume → tricuspid regurgitation→ RA dilation → right heart failure <br>- RV atrialization → reduced function of the RV → insufficient systolic contraction → functional pulmonary valve atresia → ↓ pulmonary flow → ↓ cardiac output → systemic hypoperfusion, dyspnea, and fatigue<br>- Bulging of the large sail-like anterior tricuspid leaflet into the RV → RVOTO → ↑ right heart pressure → ↑ flow through the patent foramen ovale → right-to-left shunt → cyanosis |
| **Clinical Findings**          | Varies by severity:<br>- Mild: Asymptomatic throughout adulthood<br>- Moderate: Cyanosis or heart failure in infancy or childhood<br>- Severe: In utero heart failure, nonimmune hydrops fetalis, death                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| **Diagnostics**                | - Prenatal diagnosis: fetal echocardiography<br>- Imaging: Echocardiography (confirmatory), MRI<br>- ECG: Himalayan P-wave (> 5mm) and peaked in Lead II , AV block, right axis deviation, findings of [[Atrio-ventricular reentry tachycardia]]                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| **Treatment**                  | Initial stabilization with PGE1 infusion, inhaled nitric oxide, or milrinone<br> Surgical repair aims at creating systemic-pulmonary shunt, tricuspid valve repair, and RV reconstruction<br>Age-related considerations for surgery                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| **Prognosis**                  | Varies by severity; about 30% mortality within the first year of life                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
